IDiyas

For the Inventor, By the Inventor

Dudenhofen, Germany

Hans-Juergen Teschendorf

USPTO Granted Patents = 28

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 72(Granted Patents)


Location History:

  • Ludwigshafen, DE (1982 - 1989)
  • Dudenhofen, DE (1985 - 1996)

Company Filing History:

goldMedal28 out of 10,754 
 
Basf Aktiengesellschaft
 patents

Years Active: 1982-1996

Loading Chart...
28 patents (USPTO):Explore Patents
1. 5521209 - N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the (1996-05-28),
2. 5512584 - 1,3,4-trisubstituted piperidine derivatives, the preparation and use (1996-04-30),
3. 5475105 - N-substituted azabicycloheptane derivatives (1995-12-12),
4. 5424330 - Benzofurancarboxamides having basic substituents, the preparation (1995-06-13),
5. 5424312 - Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, the preparation and (1995-06-13),
6. 5418235 - Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use (1995-05-23),
7. 5401762 - Aminoalkyl-substituted thiazolin-2-ones, the preparation and use thereof (1995-03-28),
8. 5401743 - Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation (1995-03-28),
9. 5356901 - Benzofurancarboxamides having basic substituents, the preparation (1994-10-18),
10. 5264452 - Benzofurancarboxamides and therapeutic agents (1993-11-23),
11. 5227392 - Alkoxycoumarins substituted by a heterocyclic radical, their preparation (1993-07-13),
12. 5151437 - Benzofurancarboxamides having basic substituents and therapeutic agents (1992-09-29),
13. 5073563 - Alkoxycoumarins substituted by a heterocyclic radical, their preparation (1991-12-17),
14. 5071864 - Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents (1991-12-10),
15. 4885278 - 5-substituted 10-cyanomethylenethieno(3,4-B)benzazepines (1989-12-05),

Title: Hans-Juergen Teschendorf: Innovator in Neuroleptic Compounds

Introduction

Hans-Juergen Teschendorf is a prominent inventor based in Dudenhofen, Germany, renowned for his significant contributions to the field of neuroleptic compounds. With an impressive portfolio of 28 patents, Teschendorf has made substantial advancements that hold promise for treating various diseases.

Latest Patents

Among his latest innovations are patented compounds, including N-substituted azabicyclo[3.2.0]heptane derivatives, which function as neuroleptics. Additionally, he has developed 1,3,4-trisubstituted piperidine derivatives and compounds with specific formulas, detailing their preparation and usage. These innovative compounds are designed to offer effective solutions for controlling a range of health conditions.

Career Highlights

Teschendorf is currently associated with BASF Aktiengesellschaft, a leading global chemical company. His work has not only furthered scientific knowledge but has also focused on the practical application of his inventions in the pharmaceutical industry, leading to improvements in patient care and treatment outcomes.

Collaborations

Throughout his career, Teschendorf has collaborated with several esteemed colleagues, including Liliane Unger and Gerd Steiner. These partnerships have been pivotal in enhancing the scope and impact of his research, enabling the development of novel therapeutic compounds.

Conclusion

In summary, Hans-Juergen Teschendorf is a distinguished inventor with a noteworthy track record in the realm of neuroleptic compounds. His innovative contributions and collaborations at BASF Aktiengesellschaft highlight the significance of his work in advancing medical treatment options, showcasing the vital role of inventors in driving progress in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…